# MarketFlow Additional Predictive Evidence Execution Approval for Refined Evidence Status

## Branch And Scope

- Branch: `feature/additional-predictive-evidence-execution-approval-refined-evidence-v1`.
- Base commit: `ecb476a0d5c298695753a60019f19fb19936460c`.
- Commit: recorded by this document's implementing commit after validation.
- Scope: guarded offline approval of a future research-only additional-predictive-evidence execution using reviewed refined evidence. Approval does not execute work, create results, accept predictive usefulness or profitability, or authorize runtime use.

## Approval Artifact

- Artifact/status: `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_APPROVED_FOR_REFINED_EVIDENCE` / `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_APPROVED_FOR_REFINED_EVIDENCE`.
- Schema: `additional_predictive_evidence_execution_approval_for_refined_evidence_v1`.
- Scope: `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_APPROVAL_FOR_REFINED_EVIDENCE_ONLY`.
- Objective: `EXECUTE_ADDITIONAL_PREDICTIVE_EVIDENCE_USING_REVIEWED_REFINED_FEATURE_LABEL_EVIDENCE`.
- Mode/authority: `AUTHORIZED_NOT_EXECUTED` / `AUTHORIZED_FOR_FUTURE_REFINED_EVIDENCE_EXECUTION_ONLY`.
- Approval digest: `5ad7b3b8df3156ab6b35b9490dcd4ae05bda3d1a7786212481b78d549103a8dd`.
- Reference attestation: `TEST_OPERATOR` / `2026-08-16T12:00:00Z`; a non-secret test reference for deterministic repository evidence.
- Exact phrase: `APPROVE ADDITIONAL PREDICTIVE EVIDENCE EXECUTION FOR REFINED EVIDENCE MSFT NVDA AMZN GOOGL META TSLA JPM XOM JNJ WMT CAT LMT ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_APPROVAL_FOR_REFINED_EVIDENCE_ONLY`.

## Bound Source Evidence

- Refined-evidence candidate review/candidate digests: `5cee77990a1f40689ee45ab2f65e2adda070e79970e12d52169f7e88236f6e04` / `dce3a92d05eaba5c2b9307c08799c27bbadb69e804c27c157c7290eec705c340`.
- Feature/label refinement results-review digest: `00604008d3c647f45896cd8b6707de519ed6eda4e32566b3c99910441ec6cc79`.
- Feature/label refinement execution/approval digests: `377d6d232dcdf4b94f9f2d66414ff994edca2d3d9d95f4fb97d9dbfaf2359b36` / `1b98237ae9156875ca703396b6e1fabf2acf31ab607789247f8af2391d8b5c20`.
- Original additional-predictive results-review/execution digests: `167a0399e99f46e895c9cdf6c70a3e650e20f60cb78641180de04e56f88caee8` / `61a90d0b863da3ddfc3ef8eb744a1ef64c476a975d83faa2be19d0f199776ed3`.
- Research-registry approval digest: `5f0ce29bd06f1a0d5f1ce3dd8e31b8c8e52d616673f119326377538228d3d958`.
- Canonical freeze/records digests: `02af746fa11fa292a84e000ff8ca19a0b4ab36937558f938e4ac04eef6be92fc` / `fbd7c1b17b42e5d4f82a9162b31b45fdfeef46f0e9ee7d29d74c926f0cf19044`.

## Registry-Approved Dataset Metadata

- Dataset/scope: `expanded_universe_canonical_dataset_v1` / `CANONICAL_DATASET_GENERATION_RESEARCH_ONLY`.
- Registry status/label: `APPROVED_FOR_RESEARCH_REGISTRY_ONLY` / `RESEARCH_ONLY_NON_ACTIONABLE`.
- Source profile/timeframe/range: `RTH_FULL_SESSION_1D` / `1d` / `2022-01-01` through `2025-12-31`.
- Universe/records: `12 / 11946`; data quality `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.

## Target Universe And Source Profile

- Exact order: `MSFT`, `NVDA`, `AMZN`, `GOOGL`, `META`, `TSLA`, `JPM`, `XOM`, `JNJ`, `WMT`, `CAT`, `LMT`.
- Reviewed refinement root/count/status: `.marketflow/feature_label_refinement/expanded_universe_v1/` / `12` / `REVIEWED_AND_VERIFIED`.
- META remains exactly `913` records with its limitation flag and note; every other ticker remains `1003`. No records are repaired, inferred, normalized, backfilled, or fabricated.

## Approved Refined Evidence Facts

- Labels: 7 families, 84 coverage entries, 82,698 available and 924 unavailable values; digest `04cf6925b956a0813c1b14e5009dc1fc4225179006589cc09d4f39721c749ee8`.
- Features: 9 groups, 11 categories, 19 fields, 11,946 rows, and 1,128 null/unavailable values; digest `35bf96942c57b851ee1fea7255002115fb871c9245cef849b1689411192b7f00`.
- Protocol: 6 groups with chronological splits, one-session embargo, no shuffle, and no lookahead.
- Walk-forward/OOS: 4 folds, 3,024 evaluation rows, 2,988 OOS rows, accuracy range `0.119813 to 0.480924`.
- Model/leakage: 5 model groups, 7 deterministic comparisons, 3 unavailable model-family requests, leakage `PASS / 0`.

## Authorized Future Work And Outputs

- All eleven reviewed activities are `AUTHORIZED_NOT_EXECUTED`, research-only, and non-actionable.
- All ten future outputs are `AUTHORIZED_NOT_GENERATED` and `RESEARCH_ONLY_NON_ACTIONABLE`.
- Twelve ordered per-ticker approval entries bind both source digests and deterministic per-ticker approval digests.
- The approval sets approved/authorized/ready to `True / True / True` only for future refined-evidence execution.

## Authority Boundaries

- Refined-evidence execution performed/results created: `False / False`.
- Provider requests, live transport, acquisition, dataset generation/regeneration, refinement reruns, validation reruns, metrics recomputation, and model-comparison rerun: all `False`.
- Predictive usefulness: `not accepted`; readiness/recommendation/candidate: `False / False / False`.
- Profitability: `not accepted`; readiness/recommendation: `False / False`.
- Runtime migration approved/active: `False / False`.
- Runtime/strategy/paper/broker: `NOT_AUTHORIZED / NOT_AUTHORIZED / NOT_AUTHORIZED / NOT_AUTHORIZED`.
- Automatic stitching, new strategy scoring, and trade recommendations: all `False`.
- No raw provider payload or API key is accessed, stored, committed, or printed.

## Checklist Summary

- `95 / 95` checks passed, `0` failed, `0` blockers.
- Attestation, source digests, universe/counts, refined evidence facts, approval-only scope, and every closed downstream authority are validated fail closed.

## Next Task Recommendation

- Follow-on `Additional Predictive Evidence Execution for Refined Evidence v1` is implemented on its stacked feature branch.
- This approval remains the bound source evidence for execution digest `9cf962933620f066dfb105845428a262743f9f36dbc2850838321f23de10b5fd`.
- Execution created ten ignored, research-only refined predictive-evidence outputs; predictive usefulness and profitability remain not accepted, and runtime remains not authorized.
- Next separate task: `Additional Predictive Evidence Results Review for Refined Evidence v1`.
